These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18541624)

  • 1. A new self-rating scale for detecting atypical or second-generation antipsychotic side effects.
    Waddell L; Taylor M
    J Psychopharmacol; 2008 May; 22(3):238-43. PubMed ID: 18541624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability and validity of the Korean version of UKU-SERS-Pat in patients with bipolar disorder.
    Kim JH; Choi SW; Joe SH; Ha TH; Yoo HJ; Choi JE; Cha B; Ha K
    Nord J Psychiatry; 2008; 62(6):496-502. PubMed ID: 18841509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic evaluation of rating scales for drug-induced parkinsonism and recommendations for future research.
    Knol W; Keijsers CJ; Jansen PA; van Marum RJ
    J Clin Psychopharmacol; 2010 Feb; 30(1):57-63. PubMed ID: 20075649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.
    McCann TV; Clark E; Lu S
    J Adv Nurs; 2009 Mar; 65(3):534-43. PubMed ID: 19222651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment response in psychotic patients classified according to social and clinical needs, drug side effects, and previous treatment; a method to identify functional remission.
    Alenius M; Hammarlund-Udenaes M; Hartvig P; Sundquist S; Lindström L
    Compr Psychiatry; 2009; 50(5):453-62. PubMed ID: 19683616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychosomatic aspects of neuroleptic side effects].
    Modestin J
    Z Psychosom Med Psychoanal; 1989; 35(1):30-7. PubMed ID: 2564225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 4-Point ordinal Alliance Self-report: a self-report questionnaire for assessing therapeutic relationships in routine mental health.
    Misdrahi D; Verdoux H; Lançon C; Bayle F
    Compr Psychiatry; 2009; 50(2):181-5. PubMed ID: 19216896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.
    Dolzan V; Serretti A; Mandelli L; Koprivsek J; Kastelic M; Plesnicar BK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1562-6. PubMed ID: 18573584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic agents: a survey of the prevalence, severity and burden of side effects.
    Bhavnani SM; Levin GM
    Int Clin Psychopharmacol; 1996 Mar; 11(1):1-12. PubMed ID: 8732308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of antipsychotic-induced side effects: support for the validity of a self-report (LUNSERS) versus structured interview (UKU) approach to measurement.
    Lambert TJ; Cock N; Alcock SJ; Kelly DL; Conley RR
    Hum Psychopharmacol; 2003 Jul; 18(5):405-11. PubMed ID: 12858330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abstinence, anticipation, reduction, and treatment (AART): a stepwise approach to the management of atypical antipsychotic side effects.
    Kennedy A; Tapp A; Kelly WS; Kilzieh N; Wood AE
    Essent Psychopharmacol; 2006; 7(1):1-14. PubMed ID: 16989288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glasgow Antipsychotic Side-effects Scale for Clozapine - Development and validation of a clozapine-specific side-effects scale.
    Hynes C; Keating D; McWilliams S; Madigan K; Kinsella A; Maidment I; Feetam C; Drake RJ; Haddad PM; Gaughran F; Taylor M; Clarke M
    Schizophr Res; 2015 Oct; 168(1-2):505-13. PubMed ID: 26276305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zuclopenthixol: a new generation of antipsychotic drugs. An open clinical trial.
    Matar AM; Abdel-Mawgoud M; Skov S
    J Clin Psychopharmacol; 1990 Aug; 10(4):283-6. PubMed ID: 1981068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New "atypical" neuroleptics -- the emperor's new clothes?].
    Dose M
    Psychiatr Prax; 2003 Jan; 30(1):1-3. PubMed ID: 12524575
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder: a 12-month follow up.
    Chen CK; Chen YC; Huang YS
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):17-22. PubMed ID: 19067997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
    Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
    Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of second generation antipsychotics on leptin and ghrelin.
    Esen-Danaci A; Sarandöl A; Taneli F; Yurtsever F; Ozlen N
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1434-8. PubMed ID: 18579280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side-effects and treatment with clozapine: a comparison between the views of consumers and their clinicians.
    Hodge K; Jespersen S
    Int J Ment Health Nurs; 2008 Feb; 17(1):2-8. PubMed ID: 18211398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.